Although these assays were performed in a small number of individuals (due to the limited number of cells isolated from the blood of SLE patients), our data indicate a significant reduced capability of CD69+ Treg cells from SLE patients to suppress the release of IL-10. The gene discussed is IL10; the disease is systemic lupus erythematosus.